Honors & Awards
Academic Merit Scholarship, GMCH Chandigarh2021 to 2024
Four-year scholarship for securing 3rd rank among 150 medical students in the MBBS first professional examinations.
Honors Distinction in Otolaryngology (ENT)March 2023
University exam distinction, 80%
Honors Distinction in BiochemistryFebruary 2021
University exam distinction, 77.6%
Honors Distinction in Human PhysiologyFebruary 2021
University exam distinction, 76.3%
Publications
Singh H, Nim DK, Randhawa AS, Ahluwalia S
Expert Review of Clinical Pharmacology
2024 · 17(4):381–391
A review of how artificial intelligence, spanning machine learning, natural
language processing, deep learning, and reinforcement learning, can accelerate drug discovery and
development, precision medicine, and pharmacovigilance, and how the role of the clinical
pharmacologist is evolving alongside the associated ethical and implementation challenges.
Penumetcha SS, Ahluwalia S, Irfan R, Khan SA, Rohit Reddy S, Vasquez Lopez ME, Zahid M, Busmail A, Mohammed L
Cureus
2021 · 13(12):e20483
Open Access
With antibiotic resistance eroding H. pylori eradication rates, this
PRISMA-guided systematic review synthesizes evidence on probiotics as an adjunct or alternative
therapy. Probiotics alone did not raise eradication rates, but added to standard regimens they gave
a mild improvement and, notably, significantly reduced antibiotic side effects.
Busmail A, Penumetcha SS, Ahluwalia S, Irfan R, Khan SA, Rohit Reddy S, Vasquez Lopez ME, Zahid M, Mohammed L
Cureus
2022 · 14(5):e24807
Open Access
A systematic review synthesizing evidence on the infectious and non-infectious
pulmonary complications that follow hematopoietic stem cell transplantation, from bronchiolitis
obliterans to diffuse alveolar hemorrhage and pulmonary hypertension, to help physicians recognize
and manage a serious yet under-discussed area.
Zahid M, Busmail A, Penumetcha SS, Ahluwalia S, Irfan R, Khan SA, Rohit Reddy S, Vasquez Lopez ME, Mohammed L
Cureus
2021 · 13(10):e18847
Open Access
A review of why non-selective TNF-α inhibitors failed, and even worsened,
multiple sclerosis, and how the discovery that TNF signals through two opposing receptors (TNFR1,
which drives demyelination and apoptosis; TNFR2, which promotes remyelination and neuroprotection)
reframed the target. It focuses on atrosab, a selective TNFR1-blocking antibody that
reduced symptom severity in animal models of MS.
Beyond the Pill Box: A Cross-Sectional Study of Antidiabetic Medication Adherence in Chandigarh's Elderly
Puri S, Ravikumar SR, Vashisht D, Ahluwalia S, Randhawa A
Submitted · In review, 2025
A cross-sectional study characterizing antidiabetic medication adherence among
elderly patients in Chandigarh. Manuscript submitted and currently under peer review.
Conference Presentations
Oral Presentation (first author), Pharmacology 2024, British Pharmacological Society
Ahluwalia S, Singh H, Randhawa AS. “Comparative Assessment of the Risk of
New-Onset Diabetes Mellitus between PCSK9 Inhibitors and Statins.” Harrogate, United Kingdom,
10–12 December 2024.
Poster, Pharmacology 2024, British Pharmacological Society
Randhawa AS, Singh H, Ahluwalia S. “Assessing the Risk of Osteonecrosis of
the Jaw with Bisphosphonate Therapy: Insights from the FDA Adverse Event Reporting System.”
Harrogate, United Kingdom, 10–12 December 2024.
Leadership & Community
Editor-in-Chief, IAAH Newsletter, Chandigarh BranchMay to June 2024
Indian Association for Adolescent Health
Menstrual Hygiene Drive, Bair Majra, IndiaJune 2024
Organised with The Rotaract Club, Chandigarh; health-awareness sessions for girls aged 9 to 11.
Blood Donation Camp, GMCH ChandigarhApril 2023
Eye Donation Awareness Walk, Sukhna Lake, ChandigarhAugust 2022
With Eye Bank, GMCH
